Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Howard

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravisHenning Andersen, Renato Mantegazza, Jing Jing Wang, et al.
Therapeutic Advances in Neurological Disorders|December 19, 2025
Appropriate use of steroids for patients with generalized Myasthenia Gravis: an international Delphi studyHeinz Wiendl, Hiroyuki Murai, Pushpa Narayanaswami, et al.
European Journal of Neurology|March 19, 2026
Minimal Symptom Expression in Generalized Myasthenia Gravis: A Valuable Patient-Centric Treatment GoalAndreas Meisel, Akiyuki Uzawa, Cynthia Z Qi, et al.
The Lancet. Neurology|October 20, 2023
Score fluctuation might be associated with a higher placebo rate in the RAISE trial - Authors' replyJames F Howard, Babak Boroojerdi, Guillemette de la Borderie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2013
Divergent effects of T cell costimulation and inflammatory cytokine production on autoimmune peripheral neuropathy provoked by Aire deficiencyXiaopei L Zeng, Anil Nagavalli, Colin-Jamal Smith, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 25, 2019
Eculizumab improves fatigue in refractory generalized myasthenia gravisHenning Andersen, Renato Mantegazza, Jing Jing Wang, et al.
CNS Spectrums|July 10, 2020
Response to: Eculizumab package insert recommendations for meningococcal vaccinations: call for clarity and a targeted approach for use of the drug in neuromyelitis optica spectrum disorderSean J Pittock, Ilene Weitz, James F Howard, et al.
Muscle & Nerve|December 24, 2025
The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and CanadaJose A Sanchez, Danelvis Paredes, Jeffrey T Guptill, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|December 4, 2025
Characterizing Guillain-Barré Risk Factors Among Traditional Medicare BeneficiariesBrad Wright, Samantha R Eiffert, Abagail Cirincione, et al.
Journal of the Peripheral Nervous System : JPNS|December 30, 2025
Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré SyndromeBrad Wright, Samantha R Eiffert, Abagail Cirincione, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravisHenning Andersen, Renato Mantegazza, Jing Jing Wang, et al.
Therapeutic Advances in Neurological Disorders|December 19, 2025
Appropriate use of steroids for patients with generalized Myasthenia Gravis: an international Delphi studyHeinz Wiendl, Hiroyuki Murai, Pushpa Narayanaswami, et al.
European Journal of Neurology|March 19, 2026
Minimal Symptom Expression in Generalized Myasthenia Gravis: A Valuable Patient-Centric Treatment GoalAndreas Meisel, Akiyuki Uzawa, Cynthia Z Qi, et al.
The Lancet. Neurology|October 20, 2023
Score fluctuation might be associated with a higher placebo rate in the RAISE trial - Authors' replyJames F Howard, Babak Boroojerdi, Guillemette de la Borderie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2013
Divergent effects of T cell costimulation and inflammatory cytokine production on autoimmune peripheral neuropathy provoked by Aire deficiencyXiaopei L Zeng, Anil Nagavalli, Colin-Jamal Smith, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 25, 2019
Eculizumab improves fatigue in refractory generalized myasthenia gravisHenning Andersen, Renato Mantegazza, Jing Jing Wang, et al.
CNS Spectrums|July 10, 2020
Response to: Eculizumab package insert recommendations for meningococcal vaccinations: call for clarity and a targeted approach for use of the drug in neuromyelitis optica spectrum disorderSean J Pittock, Ilene Weitz, James F Howard, et al.
Muscle & Nerve|December 24, 2025
The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and CanadaJose A Sanchez, Danelvis Paredes, Jeffrey T Guptill, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|December 4, 2025
Characterizing Guillain-Barré Risk Factors Among Traditional Medicare BeneficiariesBrad Wright, Samantha R Eiffert, Abagail Cirincione, et al.
Journal of the Peripheral Nervous System : JPNS|December 30, 2025
Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré SyndromeBrad Wright, Samantha R Eiffert, Abagail Cirincione, et al.
Pageof 14